Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • pharma-news

    pharma-news - Page 28

    Lupin Pithampur unit gets 2 USFDA observations

    Lupin Pithampur unit gets 2 USFDA observations

    Medical Dialogues Bureau13 Feb 2020 12:52 PM IST
    The inspection of the company's Pithampur Unit-I facility by the United States Food and Drug Administration (USFDA) has been completed, Lupin said in...
    Novartis cancer therapy MET inhibitor capmatinib granted USFDA priority review

    Novartis cancer therapy MET inhibitor capmatinib granted USFDA priority review

    Medical Dialogues Bureau13 Feb 2020 9:45 AM IST
    Capmatinib (INC280) is an investigational, oral, potent and selective MET inhibitor licensed to Novartis by Incyte Corporation in 2009. Under the...
    Wockhardt sells Baddi plant, 62 drug brands to Dr Reddys for Rs 1850 crore

    Wockhardt sells Baddi plant, 62 drug brands to Dr Reddys for Rs 1850 crore

    Medical Dialogues Bureau12 Feb 2020 5:23 PM IST
    Commenting on the acquisition, Dr Reddy's Co-Chairman and Managing Director G V Prasad said," the acquired portfolio shall enhance Dr Reddy''s...
    Granules India gets tentative USFDA nod for generic Colchicine capsules

    Granules India gets tentative USFDA nod for generic Colchicine capsules

    Medical Dialogues Bureau12 Feb 2020 2:34 PM IST
    New Delhi: Drug firm Granules India on Tuesday said it has received tentative approval from the US health regulator for its generic Colchicine...
    Sun Pharma arm- SPARC application for cancer drug Taclantis rejected by USFDA

    Sun Pharma arm- SPARC application for cancer drug Taclantis rejected by USFDA

    Medical Dialogues Bureau12 Feb 2020 1:10 PM IST
    "The company has received a Complete Response Letter (CRL) from the United States Food & Drug Administration (USFDA) for the new drug application...
    J B Chemicals Gujarat unit gets EIR from USFDA

    J B Chemicals Gujarat unit gets EIR from USFDA

    Medical Dialogues Bureau12 Feb 2020 1:03 PM IST
    The company has received EIR from the United States Food and Drug Administration (USFDA) for its newly set up and commissioned solid oral dosage forms...
    Zydus Cadila gets USFDA nod for Fluocinonide cream to treat skin conditions

    Zydus Cadila gets USFDA nod for Fluocinonide cream to treat skin conditions

    Medical Dialogues Bureau12 Feb 2020 12:51 PM IST
    Fluocinonide cream USP, 0.1 per cent, approved by USFDA is indicated to treat a variety of skin conditions such as psoriasis, eczema, dermatitis,...
    Sanofi asks US court to halt diabetes drug patent fight with Mylan

    Sanofi asks US court to halt diabetes drug patent fight with Mylan

    Medical Dialogues Bureau12 Feb 2020 10:30 AM IST
    In a stay application filed on Friday, Sanofi said a recent U.S. Court of Appeals for the Federal Circuit decision upholding the invalidation of two...
    NPPA fixes price of 21 formulations including diabetes drugs, others; Details

    NPPA fixes price of 21 formulations including diabetes drugs, others; Details

    Farhat Nasim11 Feb 2020 12:17 PM IST
    New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India...
    Cipla arm inks pact for anti-psychotic drug Quetiapine

    Cipla arm inks pact for anti-psychotic drug Quetiapine

    Farhat Nasim11 Feb 2020 12:15 PM IST
    New Delhi: Cipla Medpro South Africa (Pty) Ltd, a wholly-owned subsidiary of Cipla Ltd, India, has recently concluded an exclusive agreement securing...
    Cadila Healthcare Ahmedabad facility gets EIR from USFDA

    Cadila Healthcare Ahmedabad facility gets EIR from USFDA

    Medical Dialogues Bureau11 Feb 2020 12:09 PM IST
    The company's topical manufacturing facility at Ahmedabad has received an EIR from the United States Food and Drug Administration (USFDA) signifying...
    Zealand Pharma to acquire insulin pump maker Valeritas for USD 23 million

    Zealand Pharma to acquire insulin pump maker Valeritas for USD 23 million

    Medical Dialogues Bureau11 Feb 2020 11:30 AM IST
    The agreement with Zealand Pharma, which was reached following a robust and extensive marketing process, provides total cash consideration of $23...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Government of India bans Ofloxacin, Ornidazole injection combination

    Government of India bans Ofloxacin, Ornidazole injection combination

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Mediclaim cannot be rejected if duplicate bills are submitted: Consumer Forum on doctors plea

    Mediclaim cannot be rejected if duplicate bills are submitted: Consumer Forum on doctors plea

    Why Family Health Insurance Plan needs a Timely Re-Evaluation?

    Why Family Health Insurance Plan needs a Timely Re-Evaluation?

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok